Vimarsana
Biggest News Aggregation in the World

Page 28 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

500 women join Australia's landmark maternity medical device study - Vimarsana News

500 women join Australia's landmark maternity medical device study

SYDNEY, April 19, 2023 /PRNewswire/ — Medical device company Baymatob has successfully completed one of Australia’s largest maternity health studies...

500 women join Australia's landmark maternity medical device study - Vimarsana News

500 women join Australia's landmark maternity medical device study

/PRNewswire/ -- Medical device company Baymatob has successfully completed one of Australia's largest maternity health studies for a medical device, enrolling...

FDA Roundup: April 18, 2023 - Vimarsana News

FDA Roundup: April 18, 2023

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA granted...

CMS Proposes FY 2024 Inpatient Payment Policies for Hospitals | Holland & Knight LLP - Vimarsana News

CMS Proposes FY 2024 Inpatient Payment Policies for Hospitals | Holland & Knight LLP

The Centers for Medicare & Medicaid Services (CMS or Agency) on April 10, 2023, published its annual proposed rule for the federal fiscal year (FY) 2024 Inpatient Prospective Payment...

Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG - Vimarsana News

Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG

Designation represents progress for patients with suspected Coronary Microvascular Dysfunction as the FDA recognizes disease’s debilitating impacts and the lack of effective non-invasive options for efficient diagnosis